Company news

Novavax, Inc. news in 2020

Novavax, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico

December 27, 2020

Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine

December 15, 2020

Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors

December 8, 2020

Novavax Announces COVID-19 Vaccine Clinical Development Progress

November 29, 2020

Novavax Reports Third Quarter 2020 Financial and Operational Results

November 8, 2020

Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine

November 3, 2020

Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors

November 2, 2020

Novavax Announces Facility Expansion to Support Global Vaccine Development

November 1, 2020

Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

October 26, 2020

Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure

October 12, 2020

Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom

September 23, 2020

Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually

September 14, 2020

Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine

September 1, 2020

Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine

August 30, 2020

Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine

August 23, 2020

Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa

August 16, 2020

Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate

August 13, 2020

Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate

August 12, 2020

Novavax Reports Second Quarter 2020 Financial and Operational Results

August 9, 2020

Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

August 6, 2020

Novavax and Serum Institute of India Announce Development and Commercial Collaboration

August 5, 2020

Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate

August 3, 2020

Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate

July 22, 2020

Novavax Announces $1.6 Billion Funding from Operation Warp Speed

July 6, 2020

Novavax Announces Updates to Leadership Team

July 1, 2020

Novavax Expands Executive Leadership and Announces Key Promotions

June 28, 2020

Novavax Announces Additions to Executive Leadership

June 16, 2020

Novavax Appoints Biotechnology Veteran David Mott to Board of Directors

June 15, 2020

Novavax to Raise $200 Million from Private Placement with RA Capital

June 14, 2020

Novavax Awarded Department of Defense Contract for COVID-19 Vaccine

June 3, 2020

Novavax Expands Large-Scale Global Manufacturing Capacity

May 26, 2020

Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

May 24, 2020

Novavax Reports First Quarter 2020 Financial Results

May 10, 2020

Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May

April 7, 2020

Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial

March 23, 2020

Novavax Reports Fourth Quarter and Full Year 2019 Financial Results

March 10, 2020

Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development

March 9, 2020

Novavax Advances Development of Novel COVID-19 Vaccine

February 25, 2020

Novavax Granted Fast Track Designation for NanoFlu in Older Adults

January 14, 2020

Calls in 2020

Decks in 2020